For patients with stage 1 lung cancer, successful surgery is a major milestone, but a lot of stress often follows.

Researchers developed a lipid nanoparticle that delivers chemotherapy and gene-silencing RNA together, boosting immune ...

People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a ...

Patients with advanced squamous non-small-cell lung cancer who received the bispecific antibody ivonescimab alongside chemotherapy had a 40% lower risk of disease progression or death compared with ...

A paper claiming that lung cancer patients who receive immunotherapy in the morning face half the risk of tumor progression ...

Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with ...

Researchers believe immunotherapy drugs may be able to prevent or reverse graying hair In a 2017 study, scientists found that ...

In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have ...

GENEVA — Lung cancer researchers continue to be excited over the potential for immunotherapy, and the subject was given a top billing here in a keynote lecture on the first day of the European Lung ...

The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study ...